Cargando…

Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya

BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their house...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirubi, Beatrice, Ong’ang’o, Jane, Nguhiu, Peter, Lönnroth, Knut, Rono, Aiban, Sidney-Annerstedt, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256229/
https://www.ncbi.nlm.nih.gov/pubmed/34225790
http://dx.doi.org/10.1186/s40249-021-00879-4
_version_ 1783718060176179200
author Kirubi, Beatrice
Ong’ang’o, Jane
Nguhiu, Peter
Lönnroth, Knut
Rono, Aiban
Sidney-Annerstedt, Kristi
author_facet Kirubi, Beatrice
Ong’ang’o, Jane
Nguhiu, Peter
Lönnroth, Knut
Rono, Aiban
Sidney-Annerstedt, Kristi
author_sort Kirubi, Beatrice
collection PubMed
description BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya. METHODS: The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071). Treatment related costs and productivity losses were estimated. Total costs exceeding 20% of household income were defined as catastrophic and used as the outcome. Multivariable Poisson regression analysis was performed to measure the association between selected individual, household and disease characteristics and occurrence of catastrophic costs. A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored. RESULTS: The proportion of catastrophic costs among DSTB patients was 27% (n = 294). Patients with catastrophic costs had higher median productivity losses, 39 h [interquartile range (IQR): 20–104], and total median costs of USD 567 (IQR: 299–1144). The incidence of catastrophic costs had a dose response with household expenditure. The poorest quintile was 6.2 times [95% confidence intervals (CI): 4.0–9.7] more likely to incur catastrophic costs compared to the richest. The prevalence of catastrophic costs decreased with increasing household expenditure quintiles (proportion of catastrophic costs: 59.7%, 32.9%, 23.6%, 15.9%, and 9.5%) from the lowest quintile (Q1) to the highest quintile (Q5). Other determinants included hospitalization: prevalence ratio (PR) = 2.8 (95% CI: 1.8–4.5) and delayed treatment: PR = 1.5 (95% CI: 1.3–1.7). Protective factors included receiving care at a public health facility: PR = 0.8 (95% CI: 0.6–1.0), and a higher body mass index (BMI): PR = 0.97 (95% CI: 0.96–0.98). Pre TB expenditure, hospitalization and BMI were significant predictors in all sensitivity analysis scenarios. CONCLUSIONS: There are significant inequities in the occurrence of catastrophic costs. Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00879-4.
format Online
Article
Text
id pubmed-8256229
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82562292021-07-06 Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya Kirubi, Beatrice Ong’ang’o, Jane Nguhiu, Peter Lönnroth, Knut Rono, Aiban Sidney-Annerstedt, Kristi Infect Dis Poverty Research Article BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya. METHODS: The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071). Treatment related costs and productivity losses were estimated. Total costs exceeding 20% of household income were defined as catastrophic and used as the outcome. Multivariable Poisson regression analysis was performed to measure the association between selected individual, household and disease characteristics and occurrence of catastrophic costs. A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored. RESULTS: The proportion of catastrophic costs among DSTB patients was 27% (n = 294). Patients with catastrophic costs had higher median productivity losses, 39 h [interquartile range (IQR): 20–104], and total median costs of USD 567 (IQR: 299–1144). The incidence of catastrophic costs had a dose response with household expenditure. The poorest quintile was 6.2 times [95% confidence intervals (CI): 4.0–9.7] more likely to incur catastrophic costs compared to the richest. The prevalence of catastrophic costs decreased with increasing household expenditure quintiles (proportion of catastrophic costs: 59.7%, 32.9%, 23.6%, 15.9%, and 9.5%) from the lowest quintile (Q1) to the highest quintile (Q5). Other determinants included hospitalization: prevalence ratio (PR) = 2.8 (95% CI: 1.8–4.5) and delayed treatment: PR = 1.5 (95% CI: 1.3–1.7). Protective factors included receiving care at a public health facility: PR = 0.8 (95% CI: 0.6–1.0), and a higher body mass index (BMI): PR = 0.97 (95% CI: 0.96–0.98). Pre TB expenditure, hospitalization and BMI were significant predictors in all sensitivity analysis scenarios. CONCLUSIONS: There are significant inequities in the occurrence of catastrophic costs. Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00879-4. BioMed Central 2021-07-05 /pmc/articles/PMC8256229/ /pubmed/34225790 http://dx.doi.org/10.1186/s40249-021-00879-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kirubi, Beatrice
Ong’ang’o, Jane
Nguhiu, Peter
Lönnroth, Knut
Rono, Aiban
Sidney-Annerstedt, Kristi
Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title_full Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title_fullStr Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title_full_unstemmed Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title_short Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
title_sort determinants of household catastrophic costs for drug sensitive tuberculosis patients in kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256229/
https://www.ncbi.nlm.nih.gov/pubmed/34225790
http://dx.doi.org/10.1186/s40249-021-00879-4
work_keys_str_mv AT kirubibeatrice determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya
AT ongangojane determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya
AT nguhiupeter determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya
AT lonnrothknut determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya
AT ronoaiban determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya
AT sidneyannerstedtkristi determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya